ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients

Parke-Davis
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
anti-hiv-agentsdose-response-relationshipdrughiv-1hiv-infections
hiv infections, hiv-1, dose-response relationship, drug, anti-hiv agents, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 876914
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.